About NB Therapeutics
Developing Novel Therapies for Podiatry and Dermatology - Through our iontophoresis and nitric oxide gas technology platforms, NB Therapeutics seeks to address the inherent challenges of drug delivery for diseases of the skin and nails.
May 12, 2011
NB Therapeutics Appoints Jeff O'Donnell as Chairman of the Board
Jan 05 2011
NB Therapeutics Completes Enrollment in Phase 2 Onychomycosis Study
Onychomycosis is commonly known as toenail fungus. It is a chronic fungal infection affecting the toenails and fingernails of approximately 35 million patients in the U.S. alone.
Iontophoresis is the use of electric current to enhance the penetration of drugs through various surfaces on the human body, mainly skin and nails.
Nitric Oxide (NO) is a molecule of increasing interest in the medical world that has the potential to be a novel, very broad spectrum anti-infective agent.
© 2011 NB Therapeutics. All rights reserved.